Darsana Capital Partners’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-258,937
| Closed | -$19.4M | – | 13 |
|
|
2021
Q4 | $19.4M | Sell |
258,937
-441,063
| -63% | -$33.1M | 0.9% | 11 |
|
|
2021
Q3 | $81.3M | Hold |
700,000
| – | – | 2.68% | 14 |
|
|
2021
Q2 | $155M | Buy |
700,000
+200,000
| +40% | +$44.4M | 4.42% | 11 |
|
|
2021
Q1 | $66.1M | Sell |
500,000
-250,000
| -33% | -$33M | 1.85% | 17 |
|
|
2020
Q4 | $130M | Sell |
750,000
-575,000
| -43% | -$99.5M | 3.66% | 13 |
|
|
2020
Q3 | $147M | Sell |
1,325,000
-375,000
| -22% | -$41.7M | 7.5% | 7 |
|
|
2020
Q2 | $101M | Buy |
1,700,000
+350,000
| +26% | +$20.8M | 5.98% | 9 |
|
|
2020
Q1 | $90.9M | Hold |
1,350,000
| – | – | 4.3% | 9 |
|
|
2019
Q4 | $114M | Buy |
1,350,000
+350,000
| +35% | +$29.5M | 3.88% | 11 |
|
|
2019
Q3 | $74.8M | Sell |
1,000,000
-500,000
| -33% | -$37.4M | 2.77% | 12 |
|
|
2019
Q2 | $94.8M | Sell |
1,500,000
-250,000
| -14% | -$15.8M | 3.08% | 13 |
|
|
2019
Q1 | $84.3M | Sell |
1,750,000
-400,000
| -19% | -$19.3M | 3.16% | 11 |
|
|
2018
Q4 | $72M | Buy |
2,150,000
+1,325,089
| +161% | +$44.4M | 3.01% | 11 |
|
|
2018
Q3 | $43.2M | Buy |
+824,911
| New | +$43.2M | 1.36% | 15 |
|